Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to research

Considerations on Interim Evaluation of OS in Pivotal Oncology Trials

20250 citationsJournal Article

Authors

Weidong Zhang · Sana Biotechnology (United States)

Sunhee Ro · Nurix (United States)

Jing Zhao · Merck (Japan)

X. Li · National University of Misiones

Qi Jiang · Pfizer (United States)

Linda Sun · Merck (Japan)

Olga Marchenko ·

Topics & Keywords

Statistical Methods in Clinical Trials Breast Cancer Treatment Studies Advanced Radiotherapy Techniques

Publication Details

Published in: Statistics in Biopharmaceutical Research

DOI: 10.1080/19466315.2025.2606333

Field-Weighted Citation Impact: 0.00

Chengxing Lu · AstraZeneca (Switzerland)

R. Liu · Regeneron (United States)

on behalf of the Interim Evaluation of OS Workstream of the Statistical Methods in Oncology Scientific Working Group, Biopharmaceutical Section, American Statistical Association

Considerations on Interim Evaluation of OS in Pivotal Oncology Trials | Researchclopedia